393 related articles for article (PubMed ID: 2145750)
1. Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability.
Berman DS; Kiat H; Van Train KF; Friedman J; Garcia EV; Maddahi J
Am J Cardiol; 1990 Oct; 66(13):72E-79E. PubMed ID: 2145750
[TBL] [Abstract][Full Text] [Related]
2. [Myocardial scintigraphy with Tc-99m-MIBI for assessing the extent and severity of coronary disease: a comparison with thallium-201 and equilibrium angiocardioscintigraphy].
Leoncini M; Sciagrà R; Bisi G; Santoro GM; Fazzini PF
G Ital Cardiol; 1993 Feb; 23(2):127-38. PubMed ID: 8491353
[TBL] [Abstract][Full Text] [Related]
3. The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.
Berman DS; Kiat H; Maddahi J
Circulation; 1991 Sep; 84(3 Suppl):I7-21. PubMed ID: 1832100
[TBL] [Abstract][Full Text] [Related]
4. Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease.
Maddahi J; Kiat H; Van Train KF; Prigent F; Friedman J; Garcia EV; Alazraki N; DePuey EG; Nichols K; Berman DS
Am J Cardiol; 1990 Oct; 66(13):55E-62E. PubMed ID: 2145748
[TBL] [Abstract][Full Text] [Related]
5. Comparison of electrocardiographic-gated technetium-99m sestamibi single-photon emission computed tomographic imaging and rest-redistribution thallium-201 in the prediction of myocardial viability.
Duncan BH; Ahlberg AW; Levine MG; McGill CC; Mann A; White MP; Mather JF; Waters DD; Heller GV
Am J Cardiol; 2000 Mar; 85(6):680-4. PubMed ID: 12000040
[TBL] [Abstract][Full Text] [Related]
6. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.
Dilsizian V; Arrighi JA; Diodati JG; Quyyumi AA; Alavi K; Bacharach SL; Marin-Neto JA; Katsiyiannis PT; Bonow RO
Circulation; 1994 Feb; 89(2):578-87. PubMed ID: 8313546
[TBL] [Abstract][Full Text] [Related]
7. Comparison of technetium 99m methoxy isobutyl isonitrile and thallium 201 for evaluation of coronary artery disease by planar and tomographic methods.
Kiat H; Maddahi J; Roy LT; Van Train K; Friedman J; Resser K; Berman DS
Am Heart J; 1989 Jan; 117(1):1-11. PubMed ID: 2643279
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
[TBL] [Abstract][Full Text] [Related]
9. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography.
Dilsizian V; Perrone-Filardi P; Arrighi JA; Bacharach SL; Quyyumi AA; Freedman NM; Bonow RO
Circulation; 1993 Sep; 88(3):941-52. PubMed ID: 8353921
[TBL] [Abstract][Full Text] [Related]
10. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
[TBL] [Abstract][Full Text] [Related]
11. Technetium 99m sestamibi in the assessment of chronic coronary artery disease.
Berman DS; Kiat H; Van Train K; Garcia E; Friedman J; Maddahi J
Semin Nucl Med; 1991 Jul; 21(3):190-212. PubMed ID: 1835137
[TBL] [Abstract][Full Text] [Related]
12. New directions in myocardial perfusion imaging.
Beller GA
Clin Cardiol; 1993 Feb; 16(2):86-94. PubMed ID: 8435933
[TBL] [Abstract][Full Text] [Related]
13. [Myocardial scintigraphy with Tc-99m-teboroxime: its feasibility and the evaluation of its diagnostic reliability. A comparison with thallium-201 and coronary angiography].
Bisi G; Sciagrà R; Santoro GM; Cerisano G; Vella A; Zerauschek F; Fazzini PF
G Ital Cardiol; 1992 Jul; 22(7):795-805. PubMed ID: 1473653
[TBL] [Abstract][Full Text] [Related]
14. Present assessment of myocardial viability by nuclear imaging.
Saha GB; MacIntyre WJ; Brunken RC; Go RT; Raja S; Wong CO; Chen EQ
Semin Nucl Med; 1996 Oct; 26(4):315-35. PubMed ID: 8916320
[TBL] [Abstract][Full Text] [Related]
15. Technetium-99m-labelled HL91 and technetium-99m-labelled MIBI SPECT imaging for the detection of ischaemic viable myocardium: a preliminary study.
Liu M; Ma Z; Guo X; Zhu J; Su J
Clin Physiol Funct Imaging; 2012 Jan; 32(1):25-32. PubMed ID: 22152075
[TBL] [Abstract][Full Text] [Related]
16. Myocardial perfusion imaging with technetium-99m-labeled agents.
Maddahi J; Kiat H; Berman DS
Am J Cardiol; 1991 May; 67(14):27D-34D. PubMed ID: 1827941
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with technetium-99m teboroxime, a neutral, lipophilic myocardial perfusion imaging agent.
Johnson LL; Seldin DW
Am J Cardiol; 1990 Oct; 66(13):63E-67E. PubMed ID: 2220625
[TBL] [Abstract][Full Text] [Related]
18. Myocardial perfusion imaging using single-photon emission computed tomography.
Garvin AA; Cullom SJ; Garcia EV
Am J Card Imaging; 1994 Apr; 8(2):189-98. PubMed ID: 8032191
[TBL] [Abstract][Full Text] [Related]
19. Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease.
Rossetti C; Landoni C; Lucignani G; Huang G; Bartorelli AL; Guazzi MD; Margonato A; Chierchia S; Galli L; Savi A
Eur J Nucl Med; 1995 Nov; 22(11):1306-12. PubMed ID: 8575482
[TBL] [Abstract][Full Text] [Related]
20. Experimental studies of the physiologic properties of technetium-99m agents: myocardial transport of perfusion imaging agents.
Meerdink DJ; Leppo JA
Am J Cardiol; 1990 Oct; 66(13):9E-15E. PubMed ID: 2145753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
